Forskning ved Københavns Universitet - Københavns Universitet

Forside

Potential for novel MUC1 glycopeptide-specific antibody in passive cancer immunotherapy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

MUC1 is an important target for antibodies in passive cancer immunotherapy. Antibodies against mucin glycans or mucin peptide backbone alone may give rise to cross reactivity with normal tissues. Therefore, attempts to identify antibodies against cancer-specific MUC1 glycopeptide epitopes havebeen made. We recently demonstrated that a monoclonal antibody against the immunodominant Tn-MUC1 (GalNAc-α-MUC1) antigen induced ADCC in breast cancer cell lines, suggesting the feasibility of targeting combined glycopeptide epitopes in future passive cancer immunotherapy.
OriginalsprogEngelsk
TidsskriftImmunopharmacology and Immunotoxicology
Vol/bind35
Udgave nummer6
Sider (fra-til)649-52
Antal sider4
ISSN0892-3973
DOI
StatusUdgivet - dec. 2013

ID: 103647286